Cited by 1,5893D Printing in Biomedical ResearchMicrofluidic and Capillary Electrophoresis ApplicationsTissue Engineering and Regenerative Medicine

Human organs-on-chips for disease modelling, drug development and personalized medicine

Open access
Ingber, Donald E.·2022·Nature Reviews Genetics

Abstract

The failure of animal models to predict therapeutic responses in humans is a major problem that also brings into question their use for basic research. Organ-on-a-chip (organ chip) microfluidic devices lined with living cells cultured under fluid flow can recapitulate organ-level physiology and pathophysiology with high fidelity. Here, I review how single and multiple human organ chip systems have been used to model complex diseases and rare genetic disorders, to study host–microbiome interactions, to recapitulate whole-body inter-organ physiology and to reproduce human clinical responses to drugs, radiation, toxins and infectious pathogens. I also address the challenges that must be overcome for organ chips to be accepted by the pharmaceutical industry and regulatory agencies, as well as discuss recent advances in the field. It is evident that the use of human organ chips instead of animal models for drug development and as living avatars for personalized medicine is ever closer to realization. This Review discusses the types of single and multiple human organ-on-a-chip (organ chip) microfluidic devices and their diverse applications for disease modelling, drug development and personalized medicine, as well as the challenges that must be overcome for organ chips to reach their full potential.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41576-022-00466-9

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Most animal models resemble human conditions poorly and therefore predict poorly.

    “most animal models poorly resemble human conditions and thus have low predictive values.”

    From Human disease models in drug development (2023) · cites this paper as [6]

    The Introduction says animal-study results often fail to predict human results and that animal disease models can have molecular and cellular mechanisms distinct from those in humans. It does not establish that most animal models poorly resemble human conditions; it notes that some may appear phenotypically similar. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Organs-on-chips are perfused microfluidic devices with engineered or miniaturized tissues linked by 3D microchannels to mimic organ functions, biomechanics and pathophysiological responses.

    “OoCs are perfused microfluidic platforms that contain bioengineered or miniaturized tissues or organs interconnected by 3D microchannels to simulate the in vivo functions, biomechanics and (patho)physiological responses of organs6,52–54.”

    From Human disease models in drug development (2023) · cites this paper as [6]

    The Introduction describes organ chips as microfluidic devices with living cells and tissues in channels under dynamic fluid flow, designed to model organ functions and disease states. But it says only some recreate mechanical cues, while the Microfluidic organ chips section includes single-channel devices; interconnected tissues and 3D channels are therefore not defining features of all organ chips. The supplied passages have no page numbers. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Animal models frequently do not screen out drugs that are harmful or ineffective.

    “Animal models, however, often fail to filter out harmful or ineffective drugs6.”

    From Human disease models in drug development (2023) · cites this paper as [6]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ingber, D. E.
Affiliations
Boston Children's Hospital (US)
Corresponding author
Ingber, Donald E.
Venue
Nature Reviews Genetics
Published
2022-03-25
Volume
23
Issue
8
Pages
467-491
ISSN
  • 1471-0056 (ISSN-L)
  • 1471-0064
OpenAlex
W4220652963
Cited by
1,589
References
151
Citations by year
2026: 457 · 2025: 440 · 2024: 389 · 2023: 215 · 2022: 87 · 2018: 1
FWCI
25.21
Type
journal article
Language
en
Open access
Locations
  • Nature Reviews Genetics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Bill and Melinda Gates Foundation
  • National Institutes of Health
  • Defense Advanced Research Projects Agency
  • Biomedical Advanced Research and Development Authority
  • National Heart, Lung, and Blood Institute (UH3HL141797)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
organ-on-a-chip, microfluidics, disease modeling, drug development, personalized medicine, alternative to animal models, rare genetic disorders, host-microbiome interactions, drug toxicity, infectious agents, regulatory acceptance, pharmaceutical industry
MeSH terms
Drug Development, Animals, Humans, Rare Diseases, Lab-On-A-Chip Devices, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review